Inventor
Ronald FARQUHAR
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides13%
C12NMicroorganisms or enzymes13%
Y02ATechnologies for adaptation to climate change13%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms7%
C07CAcyclic or carbocyclic compounds3%
C07DHeterocyclic compounds3%
PatentTitleYear
12,577,211Probenecid compounds for the treatment of inflammasome-mediated lung disease202612,421,281Cyclosporine compositions and methods of use202512,252,556Cyclosporine compositions and methods of use202512,202,862Methods and compositions for the treatment of hepatitis B infection202511,896,628Methods and compositions for the treatment of C. difficile202411,773,141Methods and compositions for the treatment of hepatitis B infection202311,419,900Methods and compositions for the treatment of C. difficile2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to ARTUGEN THERAPEUTICS LTD (2)· patent assignee history
2022–2026Based in US· patent location history
2023–2025Patents assigned to MELBOURNE HEALTH (2)· patent assignee history
2023Patents assigned to CLEARB THERAPEUTICS LTD (1)· patent assignee history
2025–2026Patents assigned to BACAINN BIOTHERAPEUTICS LTD (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BACAINN BIOTHERAPEUTICS LTD | 3 | 2025–2026 |
| ARTUGEN THERAPEUTICS LTD | 2 | 2022–2024 |
| MELBOURNE HEALTH | 2 | 2023–2025 |
| CLEARB THERAPEUTICS LTD | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2026 |